RxDoctor Payments Data

James Thompson, MD

Obstetrics & Gynecology · Baltimore, MDNPI 1457310328

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $465 of the $565 with a category attached, or 82.3%. 8 manufacturers reported payments, led by AbbVie at 47.1% of the total. Reporting peaked in 2022 at $230 and has fallen 65.0% since, to $81 in 2024. That places this record below the midpoint for obstetrics & gynecology clinicians in MD, where the typical reported total is $508.

$565in general payments, 2019–2025

Across 24 payments — averaging $23.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$267
  • Astellas Pharma US Inc$139
  • Medicem Inc.$49
  • Organon$27
  • Therapeuticsmd, Inc.$25
  • Axonics, Inc.$22
  • plus $37 from 2 others

What the payments were for

  • Food & beverage$46582%
  • Education$10018%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)14$267
Astellas Pharma US Inc3$139
Medicem Inc.2$49
Organon1$27
Therapeuticsmd, Inc.1$25
Axonics, Inc.1$22
Pfizer1$21
Medtronic1$16

How this compares

$565 in reported general payments places this provider in the 50th percentile of 842 obstetrics & gynecology providers in Maryland.

See all obstetrics & gynecology providers in Maryland →

Medicare billing

Part B allowed, 2024
$8,553
Medicare patients
79
Services billed
110

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol25$1,311

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Baltimore

See the full list for Maryland →

Where these figures come from

Is this you, or does something look wrong? →